This public procurement contract involves the supply of medicinal products for parenteral administration containing the active ingredient propofol at a concentration of 2% (ATC group N01AX10). These products are intended for the treatment of patients in approved indications according to the Summary
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE has awarded 28 contracts to 26 suppliers.
+20 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This public procurement contract involves the regular supply of medicinal products for parenteral administration containing the active substance tigecycline (ATC group J01AA12). These products are intended for the treatment of patients in approved indications according to the Summary of Product Char
This public procurement contract involves the ongoing supply of medical devices, specifically diagnostic strips for blood glucose testing. Suppliers are invited to provide these essential health products to support diabetes management. The total value of the contract is €5,250,000, and it is publish
This public procurement contract involves the repeated supply of specialized medical materials (SMM) in accordance with the current Medical Devices Act. The focus is on short-term catheter-based mechanical heart support systems necessary for treating patients at the buyer's facilities. The expected
This public procurement contract involves the repeated supply of specialized medical materials in accordance with the applicable medical device legislation. The focus is on balloon dilatation catheters that release sirolimus, which are essential for treating patients at the buyer's facilities. Suppl
Apply for up to £500,000 to establish the Medicines Manufacturing Data Institute, a trusted data hub for the medicines ecosystem, with potential for up to £5 million phase 2 funding.
UHN seeks a consultant-led ENT service provider to manage comprehensive patient pathways, improve access, and ensure RTT compliance.
A track and trace system to manage sterile instrument and equipment movement throughout the sterilization and distribution process in hospital central sterile services departments.
Leicester City Council is seeking provider input through a Soft Market Test to inform future commissioning of inpatient detoxification services for people using drugs and alcohol.
